Joint (NASDAQ:JYNT) Major Shareholder Charles Jobson Acquires 13,000 Shares

Key Points

  • Charles Jobson, a major shareholder, purchased 13,000 shares of The Joint Corp. on Dec. 1 at an average price of $8.41, raising his direct stake to 1,605,027 shares (a 0.82% ownership increase) per an SEC filing.
  • The stock traded around $8.38 (12‑month range $7.50–$13.47) with a market cap of about $124.6M and a negative P/E; the company reported $0.02 EPS last quarter, beating estimates, with revenue roughly in line.
  • Analysts maintain a consensus "Hold" rating with an average price target of $17.00, and institutional investors own roughly 76.9% of the shares with several funds recently increasing positions.

The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson acquired 13,000 shares of the business's stock in a transaction on Monday, December 1st. The stock was acquired at an average cost of $8.41 per share, with a total value of $109,330.00. Following the acquisition, the insider directly owned 1,605,027 shares in the company, valued at approximately $13,498,277.07. This trade represents a 0.82% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.

Joint Stock Up 1.3%

Shares of NASDAQ:JYNT opened at $8.38 on Thursday. The Joint Corp. has a 12-month low of $7.50 and a 12-month high of $13.47. The company's 50 day moving average price is $8.47 and its two-hundred day moving average price is $10.10. The firm has a market cap of $124.58 million, a PE ratio of -139.64 and a beta of 1.30.

Joint (NASDAQ:JYNT - Get Free Report) last issued its quarterly earnings results on Friday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business had revenue of $13.38 million during the quarter, compared to analysts' expectations of $13.36 million. Joint had a negative return on equity of 0.98% and a negative net margin of 1.78%. On average, research analysts expect that The Joint Corp. will post 0.11 EPS for the current year.

Analyst Upgrades and Downgrades




JYNT has been the topic of a number of recent analyst reports. Weiss Ratings restated a "sell (e+)" rating on shares of Joint in a research report on Wednesday, October 8th. B. Riley downgraded shares of Joint from a "buy" rating to a "hold" rating in a research note on Friday, November 7th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $17.00.

Check Out Our Latest Stock Report on JYNT

Institutional Trading of Joint

Institutional investors and hedge funds have recently modified their holdings of the business. Skylands Capital LLC grew its position in Joint by 6.8% in the third quarter. Skylands Capital LLC now owns 832,278 shares of the company's stock valued at $7,940,000 after acquiring an additional 52,983 shares during the last quarter. JCP Investment Management LLC boosted its stake in shares of Joint by 24.0% in the 3rd quarter. JCP Investment Management LLC now owns 593,906 shares of the company's stock valued at $5,666,000 after purchasing an additional 115,062 shares in the last quarter. Topline Capital Management LLC grew its holdings in shares of Joint by 18.7% during the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company's stock valued at $5,184,000 after purchasing an additional 70,910 shares during the last quarter. Alta Fox Capital Management LLC bought a new stake in shares of Joint during the 1st quarter valued at approximately $5,035,000. Finally, Geode Capital Management LLC increased its position in Joint by 17.6% during the 2nd quarter. Geode Capital Management LLC now owns 345,330 shares of the company's stock worth $3,986,000 after purchasing an additional 51,704 shares in the last quarter. 76.88% of the stock is currently owned by institutional investors.

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Joint?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Joint and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles